港股生物医药板块今日遭遇重挫，其中荣昌生物（09995.HK）盘中大跌9.81%，引发市场广泛关注。
消息面上，美国总统特朗普于当地时间4月8日发表讲话，宣布美国将对药品征收关税。特朗普表示，美国支付的药品价格往往比药品生产国高出很多倍，征收关税旨在鼓励制药公司在美国本土设厂。这一消息对整个生物医药板块造成了显著冲击，多家中国生物科技公司股价应声下跌。
分析人士指出，此举可能会对中国生物医药企业的出口业务产生不利影响，增加其进入美国市场的成本。作为行业领先的生物制药公司，荣昌生物的股价下跌反映了投资者对未来业务发展的担忧。然而，具体影响程度还需要等待更多细节公布。投资者应密切关注事态发展，评估潜在风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.